COMMD8 changes expression during initial phase of wasp venom immunotherapy
- PMID: 32559011
- DOI: 10.1002/jgm.3243
COMMD8 changes expression during initial phase of wasp venom immunotherapy
Abstract
Background: Hymenoptera venom allergy (HVA) is of great concern because of the possibility of anaphylaxis, which may be fatal. Venom immunotherapy (VIT) is the only disease-modifying treatment in HVA and, although efficient, its mechanism remains partially unknown. Gene expression analysis may be helpful for establishing a proper model of tolerance induction during the build-up phase of VIT. The present study aimed to analyze how the start of VIT changes the expression of 15 selected genes.
Methods: Forty-five patients starting VIT with a wasp venom allergy were enrolled. The diagnosis was established based on anaphylaxis history (third or fourth grade on the Mueller scale) and positive soluble immunoglobulin E and/or skin tests. Two blood collections were performed in the patient group: before and after 3 months of VIT. One sample was taken in the control group. Gene expression analysis was performed using a reverse transcriptase-polymerase chain reaction with microfluidic cards and normalized to the 18S housekeeping gene.
Results: Commd8 was the only gene that changed expression significantly after the start of VIT (p = 0.012). Its expression decreased towards the levels observed in the healthy controls. Twelve out of 15 genes (commd8, cldn1, cngb3, fads1, hes6, hla-drb5, htr3b, prlr, slc16a4, snx33, socs3 and twist2) revealed a significantly different expression compared to the healthy controls.
Conclusions: The present study shows that commd8 changes significantly its expression during initial phase of VIT. This gene might be a candidate for VIT biomarker in future studies.
Keywords: RNA; allergy; gene expression; immune response.
© 2020 John Wiley & Sons, Ltd.
References
REFERENCES
-
- Bilo BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8:330-337.
-
- Tejedor Alonso MA, Moro Moro M, Múgica García MV. Epidemiology of anaphylaxis. Clin Exp Allergy. 2015;45:1027-1039.
-
- Schwartz HJ, Squillace DL, Sher TH, Teigland JD, Yunginger JW. Studies in stinging insect hypersensitivity: postmortem demonstration of antivenom IgE antibody in possible sting-related sudden death. Am J Clin Pathol. 1986;85:607-610.
-
- Nittner-Marszalska M, Liebhart J, Liebhart E, et al. Prevalence of hymenoptera venom allergy and its immunological markers current in adults in Poland. Med Sci Monit. 2004;10:CR324-CR329.
-
- Bilo MB, Pravettoni V, Bignardi D, et al. Hymenoptera venom allergy: Management of Children and Adults in clinical practice. J Investig Allergol Clin Immunol. 2019;29:180-205.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials